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LAD that wrapped
around the apex
(n=206)
LAD that terminated at
or before the apex
(n=147)
p-
value
Time from symptom
onset to ﬁrst device
(min)
146 [119, 200] 158 [127, 222] 0.05
Occlusion at proximal
LAD
48.3% 51.7% 0.53
Pre PCI TIMI ﬂow
grade 0 or 1
68.4% 74.8% 0.19
Final TIMI ﬂow grade
3
94.2% 89.8% 0.13
% infarct mass of LV
mass (%) at 30 days
17.1 [7.9, 24.5] 16.8 [7.2, 22.8] 0.30
LV end diastolic
volume (mL) at 30
days
181 [150, 213] 166 [142, 197] 0.05
LV end systolic
volume (mL) at 30
days
89 [68, 117] 81 [64, 105] 0.06
MACHFE 8.9% (18) 3.4% (5) 0.05
New onset of severe
heart failure
6.9% (14) 2.0% (3) 0.04
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SConclusions: Among the higher-risk cohort of patients with positive biomarkers
within the ACUITY trial, bivalirudin monotherapy (compared with heparin + GPI)
was associated with similar risk of ischemic events and signiﬁcant reduction of major
bleeding at 30 days and 1 year in patients undergoing PCI.
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Background: The efﬁcacy and safety of drug-eluting stents in STEMI patients is still
controversial and implantation of a bare-metal stent (BMS) is commonly preferred in
this patient population. The COMFORTABLE AMI trial has recently shown that, in
STEMI patients, a Biolimus A9-eluting stent with biodegradable polymer (BES) is
more effective and safer compared to BMS after 2 years follow-up. The e-BioMatrix
registry has evaluated the long-term safety and efﬁcacy of BES in a large real-world
patient population including patients with ST elevation myocardial infarction
(STEMI), non-ST elevation myocardial infarction (NSTEMI) and stable ischemic
heart disease (SIHD).
Methods: A total number of 959 STEMI, 1810 NSTEMI and 2785 SIHD patients
were enrolled. The primary endpoint was MACE, deﬁned as a composite of
cardiac death, MI and clinically-indicated TVR at 12 months. Secondary
endpoints were MACE at 30 days, 6 months, 2, 3, and 5 years, ARC deﬁned stent
thrombosis and total revascularization rates at 30 days, 6 months and 12 months,
2, 3, and 5 years. DAPT was mandatory for 6 months and recommended up to 12
months.
Results: MACE rates at 12 months were similar in all 3 patients groups: STEMI
(3.9%), NSTEMI (4.7%) and SIHD (4.2%) p¼NS. The rates of deﬁnite stent
thrombosis (ST) were also low in all 3 groups: STEMI (1.0%), NSTEMI (0.4%),
SIHD (0.4%) (STEMI vs. SIHD (p¼0.046), all other pairwise comparisons were NS).
The complete analysis of the outcomes is ongoing.
Conclusions: The use of Biolimus A9-eluting stents is safe and efﬁcient in STEMI,
NSTEMI and SIHD patients at 12-months follow-up. The complete analysis will be
reported for the ﬁrst time during this presentation.
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Background: The impact of left anterior descending artery (LAD) length on left
ventricular (LV) remodeling in pts with anterior ST-elevation myocardial infarction
(STEMI) has not been fully investigated.
Methods: INFUSE-AMI was an open-label, 22 factorial, randomized, multicenter,
single-blind evaluation of bolus intralesion abciximab and manual aspiration
thrombectomy in pts undergoing bivalirudin supported primary PCI for anterior
STEMI. Among 452 enrolled pts, 372 pts with available cardiac magnetic resonance
imaging (cMRI) at 30 days were categorized based on coronary angiography as
having an LAD that supplied inferior wall myocardium vs. an LAD that terminated atB86 JACC Vol 62/18/Suppl B j October 2or before the apex. Major adverse cardiac and heart failure events (MACHFE) were
death, reinfarction, new onset severe heart failure, or rehospitalisation for heart
failure.
Results: Because of poor ﬁnal TIMI ﬂow (0/1) or poor angiography quality, LADs
in 19 pts could not be categorized. Among the remaining 353 pts, 206 (58%) had
an LAD that wrapped around the apex. Although the time from symptom-onset to
ﬁrst device was signiﬁcantly shorter in LADs that wrapped around the apex
and although the frequency of proximal occlusion location and % infarct mass
were similar, LV end diastolic and systolic volumes (assessed by cMRI) at 30 days
were larger than in pts with LADs that terminated before the apex (Table). At 1
year, the rates of MACHFE as well as new onset of severe heart failure and
rehospitalisation for heart failure were signiﬁcantly higher in pts with LADs that
wrapped around the apex compared to pts with LADs that terminated before the
apex.
Conclusions: LAD length is an important determinant of prognosis in pts with
anterior STEMI. In these pts, an LAD that wraps around the apex to supply inferior
wall myocardium is associated with unfavourable LV remodeling and subsequent
heart failure.TCT-264
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Background: Long term prognosis of left ventricular (LV) systolic function was well
known but LV diastolic function in patients with ST segment elevation myocardial
infarction (STEMI) who underwent primary percutaneous coronary intervention (PCI)
was not studied well.
Methods: A consecutive 325 patients treated with primary PCI. Transthoracic
echocardiography was performed within 24 hour after PCI and at 12 months follow-
up. The indices of LV systolic function (LV ejection fraction-EF, wall motion score
index-WMSI), LV diastolic function (The ratio of the transmitral and myocardial early
diastolic velocities (E/Em)) and LV dimension were measured.
Results: At 12 month follow-up, we observed the signiﬁcant improvement of
LVEF (49.19.8 % to 53.910.3 %, p < 0.01), the decrease of WMSI
(1.420.36 to 1.330.37, p < 0.001) and signiﬁcant decrease in LV end diastolic
dimension(52.1  6.6 to 49.86.8). But, there was no signiﬁcant difference but
numerically worsening LV diastolic function (E/Em 12.75.4 to 13.6 7.8,
p¼0.38).
Conclusions: The LV systolic function was improved but LV diastolic function was
not improved after STEMI treated with primary PCI.7–November 1, 2013 j TCT Abstracts/POSTER/STEMI/NSTEMI/ACS
